Tazarotene in combination with topical corticosteroids
- PMID: 9777792
- DOI: 10.1016/s0190-9622(98)70311-1
Tazarotene in combination with topical corticosteroids
Abstract
The use of a topical corticosteroid in combination with tazarotene has theoretic appeal because each drug has a different mechanism of action, and it is therefore likely that combination therapy will offer additive or synergistic effects. For example, the steroid may promote a rapid initial response together with minimization of erythema during the treatment period, and tazarotene may prolong the duration of the therapeutic effect and lower the probability of relapse. The results of a large, controlled clinical trial in which corticosteroids of various potencies were added to tazarotene therapy showed that tazarotene plus a medium- or high potency corticosteroid produced greater and more rapid efficacy, and superior tolerability, than tazarotene plus placebo cream.
Similar articles
-
Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):590-6. doi: 10.1016/s0190-9622(98)70008-8. J Am Acad Dermatol. 1998. PMID: 9777766 Clinical Trial.
-
A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.J Cutan Med Surg. 2002 Mar-Apr;6(2):95-102. doi: 10.1007/s10227-001-0031-z. Epub 2002 Feb 13. J Cutan Med Surg. 2002. PMID: 11992180 Clinical Trial.
-
Topical tazarotene: a review of its use in the treatment of plaque psoriasis.Am J Clin Dermatol. 2005;6(4):255-72. doi: 10.2165/00128071-200506040-00006. Am J Clin Dermatol. 2005. PMID: 16060713 Review.
-
Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis.Br J Dermatol. 1999 Apr;140 Suppl 54:18-23. doi: 10.1046/j.1365-2133.1999.140s54018.x. Br J Dermatol. 1999. PMID: 10731130 Clinical Trial.
-
Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid.J Am Acad Dermatol. 2000 Aug;43(2 Pt 3):S43-6. doi: 10.1067/mjd.2000.108319. J Am Acad Dermatol. 2000. PMID: 10898829 Review.
Cited by
-
New and Emerging Topical Therapies for Psoriasis and Atopic Dermatitis.J Clin Aesthet Dermatol. 2019 Dec;12(12):28-34. Epub 2019 Dec 1. J Clin Aesthet Dermatol. 2019. PMID: 32038762 Free PMC article. Review.
-
Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults.Clin Cosmet Investig Dermatol. 2020 Jun 11;13:391-398. doi: 10.2147/CCID.S252426. eCollection 2020. Clin Cosmet Investig Dermatol. 2020. PMID: 32606876 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical